The dual-targeting CAR T-cell therapy KITE-363 showed positive response rates and manageable side effects in relapsed or ...

Minimal residual disease-negativity after treatment in DLBCL strongly correlates with remission and overall survival. However ...

OLD man whose cancer has returned for a third time is hoping for a stem cell donor to enable him to have the treatment.

Radionuclide therapy with the radioactive element terbium could effectively combat lymphoma. This is demonstrated by ...

The Lymphoma Research Foundation, the nation's largest nonprofit organization devoted to funding innovative lymphoma research and serving the lymphoma community, has awarded 24 new research grants in ...

A newly renovated multi-family home in Brookline is offering free stays to families who travel to the Boston area because a loved one needs treatment for cancer.

A groundbreaking study has unveiled a promising new therapy for lymphoma using the radioactive isotope terbium-161 ...

Kite Pharma’s bicistronic CAR T-cell therapy hit the main goal of a phase 1a trial, with zero dose-limiting toxicities (DLTs) ...

The cancer can be effectively combated with the radioactive element terbium. However, the therapy has not yet been tested on ...

A home-based care program improved urgent visits, symptom burden, and daily function, despite not having a significant effect on hospital admissions and ED visits.

The following is a summary of “A real-world pharmacovigilance assessment and literature review of lymphoma development in ...